Items where authors include "Fuller, H."
Up a levelArticle
Sun, G., Fuller, H., Fenton, H. et al. (7 more authors) (2024) The effect of aspirin and eicosapentaenoic acid on urinary biomarkers of prostaglandin E2 synthesis and platelet activation in participants of the seAFOod polyp prevention trial. International Journal of Cancer, 154 (5). pp. 873-885. ISSN 0020-7136
Davies, J.R. orcid.org/0009-0002-4272-2477, Mell, T. orcid.org/0009-0001-6744-1340, Fuller, H. orcid.org/0000-0001-8381-519X et al. (10 more authors) (2023) Polymorphisms in Cyclooxygenase, Lipoxygenase, and TP53 Genes Predict Colorectal Polyp Risk Reduction by Aspirin in the seAFOod Polyp Prevention Trial. Cancer Prevention Research, 16 (11). pp. 621-630. ISSN 1940-6207
Davies, J.R. orcid.org/0009-0002-4272-2477, Mell, T. orcid.org/0009-0001-6744-1340, Fuller, H. orcid.org/0000-0001-8381-519X et al. (10 more authors) (2023) Polymorphisms in Cyclooxygenase, Lipoxygenase, and TP53 Genes Predict Colorectal Polyp Risk Reduction by Aspirin in the seAFOod Polyp Prevention Trial. Cancer Prevention Research, 16 (11). pp. 621-630. ISSN 1940-6207
Sun, G., Fuller, H., Fenton, H. et al. (7 more authors) (2023) The effect of aspirin and eicosapentaenoic acid on urinary biomarkers of prostaglandin E2 synthesis and platelet activation in participants of the seAFOod polyp prevention trial. International Journal of Cancer. ISSN 0020-7136
Fuller, H., Race, A.D., Fenton, H. et al. (7 more authors) (2023) Plasma and rectal mucosal oxylipin levels during aspirin and eicosapentaenoic acid treatment in the seAFOod polyp prevention trial. Prostaglandins, Leukotrienes and Essential Fatty Acids, 192. 102570. ISSN 0952-3278
Fuller, H., Race, A.D., Fenton, H. et al. (7 more authors) (2023) Plasma and rectal mucosal oxylipin levels during aspirin and eicosapentaenoic acid treatment in the seAFOod polyp prevention trial. Prostaglandins, Leukotrienes and Essential Fatty Acids, 192. 102570. ISSN 0952-3278